BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.221
-0.002 (-0.81%)
Apr 29, 2026, 10:45 AM EDT - Market open

BioRestorative Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-14.24-8.98-10.42-13.22-44.3
Upgrade
Depreciation & Amortization
0.210.190.170.120.09
Upgrade
Other Amortization
----1.13
Upgrade
Stock-Based Compensation
3.332.817.7812.6123.11
Upgrade
Other Operating Activities
-1.39-2.28-4.48-5.4416.32
Upgrade
Change in Accounts Receivable
0.17-0.17-0-0.010.01
Upgrade
Change in Accounts Payable
0.840.290.020.12-0.07
Upgrade
Change in Other Net Operating Assets
0.3-0.10.5-0.090.38
Upgrade
Operating Cash Flow
-10.79-8.23-6.43-5.91-3.33
Upgrade
Capital Expenditures
-0.12-0.11-0.17-0.27-0.03
Upgrade
Sale (Purchase) of Intangibles
----0.18-
Upgrade
Investment in Securities
9.010.623.42-12.96-
Upgrade
Investing Cash Flow
8.90.513.25-13.4-0.03
Upgrade
Long-Term Debt Issued
----0.25
Upgrade
Total Debt Issued
----0.25
Upgrade
Net Debt Issued (Repaid)
----0.25
Upgrade
Issuance of Common Stock
3.148.122.35-21.07
Upgrade
Other Financing Activities
-0.28-0.74---
Upgrade
Financing Cash Flow
2.857.382.35-21.32
Upgrade
Net Cash Flow
0.96-0.34-0.83-19.3117.96
Upgrade
Free Cash Flow
-10.91-8.34-6.6-6.18-3.36
Upgrade
Free Cash Flow Margin
-3031.70%-2078.94%-4527.61%-5157.20%-7305.58%
Upgrade
Free Cash Flow Per Share
-1.21-1.07-1.56-1.71-2.83
Upgrade
Levered Free Cash Flow
-6.2-3.11-5.086.155.7
Upgrade
Unlevered Free Cash Flow
-6.2-3.11-5.086.155.71
Upgrade
Change in Working Capital
1.310.030.520.010.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.